Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India Read more
Gilead’s Livdelzi wins FDA approval, can challenge Ocaliva dominance in primary biliary cholangitis market Read more
Madrigal Pharmaceuticals poised for market dominance with Rezdiffra’s first full quarter success and growing MASH market potential Read more